{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T23:52:07Z","timestamp":1788393127682,"version":"build-2803163510"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100005196","name":"Bureau of Justice Assistance","doi-asserted-by":"publisher","award":["16-DJ-BX-0083"],"award-info":[{"award-number":["16-DJ-BX-0083"]}],"id":[{"id":"10.13039\/100005196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Justice"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s40352-019-0089-6","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T10:04:13Z","timestamp":1559037853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Probation clients\u2019 barriers to access and use of opioid use disorder medications"],"prefix":"10.1186","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7239-7030","authenticated-orcid":false,"given":"Jessica","family":"Reichert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily","family":"Gleicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,28]]},"reference":[{"key":"89_CR1","volume-title":"Trends in the use of methadone, buprenorphine, and extended-release naltrexone at substance abuse treatment facilities: 2003\u20132015 (update)","author":"CE Alderks","year":"2017","unstructured":"Alderks, C. E. (2017). Trends in the use of methadone, buprenorphine, and extended-release naltrexone at substance abuse treatment facilities: 2003\u20132015 (update). Rockville: Substance Abuse Mental Health Services Administration Retrieved from https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/report_3192\/ShortReport-3192.html ."},{"key":"89_CR2","unstructured":"American Medical Association. (2018). An open letter to the Senate Committee on Finance [web post]. Chicago: American Medical Association Retrieved from https:\/\/searchlf.ama-assn.org\/undefined\/documentDownload?uri=%2Funstructured%2Fbinary%2Fletter%2FLETTERS%2F2018-2-16-AMA-Opioid-Recommendations-Ltr-SFC-02-16-18.pdf ."},{"key":"89_CR3","volume-title":"The psychology of criminal conduct","author":"DA Andrews","year":"2010","unstructured":"Andrews, D. A., & Bonta, J. (2010). The psychology of criminal conduct (5th ed.). New York: Routledge.","edition":"5"},{"issue":"2","key":"89_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/0032885512438836","volume":"92","author":"SJ Bahr","year":"2012","unstructured":"Bahr, S. J., Masters, A. L., & Taylor, B. M. (2012). What works in substance abuse treatment programs for offenders? The Prison Journal, 92(2), 155\u2013174.","journal-title":"The Prison Journal"},{"issue":"3","key":"89_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/10550887.2012.694598","volume":"31","author":"G Bart","year":"2012","unstructured":"Bart, G. (2012). Maintenance medication for opiate addiction: The foundation of recovery. Journal of Addictive Diseases, 31(3), 207\u2013225. https:\/\/doi.org\/10.1080\/10550887.2012.694598 .","journal-title":"Journal of Addictive Diseases"},{"key":"89_CR6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.drugalcdep.2004.08.023","volume":"77","author":"S Belenko","year":"2005","unstructured":"Belenko, S., & Peugh, J. (2005). Estimating drug treatment needs among state prison inmates. Drug and Alcohol Dependence, 77, 269\u2013281.","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"89_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.drugpo.2007.11.019","volume":"19","author":"RD Bruce","year":"2008","unstructured":"Bruce, R. D., & Schleifer, R. A. (2008). Ethical and human rights imperatives to ensure medication-assisted treatmetn for opioid dependence in prisons and pre-trial detention. International Journal of Drug Policy, 19(1), 17\u201323.","journal-title":"International Journal of Drug Policy"},{"issue":"6","key":"89_CR8","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1111\/1475-6773.12201","volume":"49","author":"RE Clark","year":"2014","unstructured":"Clark, R. E., Baxter, J. D., Barton, B. A., Aweh, G., O\u2019Connell, E., & Fisher, W. H. (2014). The Impact of prior authorization on buprenorphine dose, relapse rates, and cost for Massachusetts medicaid beneficiaries with opioid dependence. Health Services Research, 49(6), 1964\u20131979. https:\/\/doi.org\/10.1111\/1475-6773.12201 .","journal-title":"Health Services Research"},{"issue":"9","key":"89_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta11090","volume":"11","author":"M Connock","year":"2007","unstructured":"Connock, M., Juarez-Garcia, A., Jowett, S., Frew, E., Liu, Z., Taylor, R. J., Fry-Smith, A., et al. (2007). Methadone and buprenorphine for the management of opioid dependence: A systematic review and economic evaluation. Health Technology Assessment, 11(9), 1\u2013171.","journal-title":"Health Technology Assessment"},{"key":"89_CR10","first-page":"109","volume":"3","author":"FT Cullen","year":"2000","unstructured":"Cullen, F. T., & Gendreau, P. (2000). Assessing correctional rehabilitation: Policy, practice, and prospects. Criminal Justice, 3, 109\u2013175.","journal-title":"Criminal Justice"},{"key":"89_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2194-7899-1-5","volume":"1","author":"LJ Ducharme","year":"2013","unstructured":"Ducharme, L. J., Chandler, R. K., & Wilery, T. R. A. (2013). Implementing drug abuse treatment services in criminal justice settings: Introduction to the CJ-DATS protocol series. Health & Justice, 1, 1\u20136.","journal-title":"Health & Justice"},{"key":"89_CR12","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10610-017-9349-y","volume":"24","author":"D Farabee","year":"2018","unstructured":"Farabee, D. (2018). Current and promising pharmacotherapies for substance use disorder among justice-involved populations. European Journal of Crime Policy Research, 24, 145\u2013153.","journal-title":"European Journal of Crime Policy Research"},{"issue":"1","key":"89_CR13","first-page":"3","volume":"62","author":"D Farabee","year":"1998","unstructured":"Farabee, D., Prendergast, M., & Anglin, M. D. (1998). The effectiveness of coerced treatment for drug-abusing offenders. Federal Probation, 62(1), 3\u201310.","journal-title":"Federal Probation"},{"key":"89_CR14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.drugalcdep.2016.08.003","volume":"167","author":"NE Fearn","year":"2016","unstructured":"Fearn, N. E., Vaughn, M. G., Nelson, E. J., Salas_Wright, C. P., DeLisi, M., & Qian, Z. (2016). Trends and correlates of substance use disorders among probationers and parolees in the United States, 2002-2014. Drug and Alcohol Dependence, 167, 128\u2013139.","journal-title":"Drug and Alcohol Dependence"},{"key":"89_CR15","unstructured":"Feucht, T. E., & Gfroerer, J. (2011). Mental and substance use disorders among adult men on probation or parole: Some success against a persistent challenge. Substance Abuse and Mental Health Services Administration Data Review."},{"key":"89_CR16","volume-title":"Implementation research: A synthesis of the literature","author":"DL Fixsen","year":"2005","unstructured":"Fixsen, D. L., Naoom, S. F., Blase, K. A., Friedman, R. M., & Wallace, F. (2005). Implementation research: A synthesis of the literature. Tampa: University of South Florida, Louis de la Parte Florida Mental Health Institute, The National Implementation Research Network (FMHI Publication #231)."},{"key":"89_CR17","volume-title":"Principles of drug abuse treatment for criminal justice populations: A research-based guide","author":"B Fletcher","year":"2014","unstructured":"Fletcher, B. (2014). Principles of drug abuse treatment for criminal justice populations: A research-based guide. Bethesda: U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse."},{"issue":"1","key":"89_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/08897077.2011.611460","volume":"33","author":"PD Friedmann","year":"2012","unstructured":"Friedmann, P. D., Hoskinson, R., Gordon, M., Schwartz, R., Kinlock, T., Knight, K., et al. (2012). Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): Availability, barriers, and intentions. Substance Abuse, 33(1), 9\u201318. https:\/\/doi.org\/10.1080\/08897077.2011.611460 .","journal-title":"Substance Abuse"},{"issue":"3","key":"89_CR19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jsat.2006.12.020","volume":"32","author":"PD Friedmann","year":"2006","unstructured":"Friedmann, P. D., Taxman, F. S., & Henderson, C. E. (2006). Evidence-based treatment practices for drug-incolved adults in the criminal justice system. Journal of Substance Abuse Treatment, 32(3), 267\u2013277.","journal-title":"Journal of Substance Abuse Treatment"},{"key":"89_CR20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jsat.2014.10.001","volume":"50","author":"PD Friedmann","year":"2015","unstructured":"Friedmann, P. D., Wilson, D., Knudsen, H. K., Ducharme, L. J., Welsh, W. N., Frisman, L., et al. (2015). Effect of an organizational linkage intervention on staff perceptions of medication-assisted treatment and referral intentions in community corrections. Journal of Substance Abuse Treatment, 50, 50\u201358.","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"89_CR21","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1176\/appi.ps.201300235","volume":"65","author":"CA Fullerton","year":"2014","unstructured":"Fullerton, C. A., Kim, M., Thomoas, C. P., Lyman, D. R., Montejano, L. B., Dougherty, R. H., et al. (2014). Medication-assisted treatment with methadone: Assessing the evidence. Psychiatric Services, 65(2), 1146\u20131157.","journal-title":"Psychiatric Services"},{"issue":"3","key":"89_CR22","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1360-0443.2007.02090.x","volume":"103","author":"A Gibson","year":"2008","unstructured":"Gibson, A., Degenhardt, L., Mattick, R. P., Ali, R., White, J., & O\u2019Brien, S. (2008). Exposure to opioid maintenance treatment reduces long-term mortality. Addiction, 103(3), 462\u2013468.","journal-title":"Addiction"},{"key":"89_CR23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1080\/08897077.2011.616816","volume":"33","author":"J Gryczynski","year":"2012","unstructured":"Gryczynski, J., Kinlock, T. W., Kelly, S. M., O\u2019Grady, K. E., Gordon, M. S., & Schwarz, R. P. (2012). Opioid agonist maintenance for probationers: Patient-level predictors of treatment retention, drug use, and crime. Substance Abuse, 33, 30\u201339. https:\/\/doi.org\/10.1080\/08897077.2011.616816 .","journal-title":"Substance Abuse"},{"issue":"4","key":"89_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1300\/J126v02n04_07","volume":"2","author":"PF Hora","year":"2014","unstructured":"Hora, P. F. (2014). Professionals need to learn about opioid replacement therapy. Journal of Maintenance in the Addictions, 2(4), 71\u201376.","journal-title":"Journal of Maintenance in the Addictions"},{"key":"89_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2017.04.005","volume":"78","author":"AS Huhn","year":"2017","unstructured":"Huhn, A. S., & Dunn, K. E. (2017). Why aren\u2019t physicians prescribing more buprenorphine? Journal of Substance Abuse Treatment, 78, 1\u20137.","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"89_CR26","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1370\/afm.1595","volume":"12","author":"E Hutchinson","year":"2014","unstructured":"Hutchinson, E., Catlin, M., Andrilla, C. H., Baldwin, L. M., & Rosenblatt, R. A. (2014). Barriers to primary care physicians prescribing buprenorphine. Annals of Family Medicine, 12(2), 128\u2013133.","journal-title":"Annals of Family Medicine"},{"issue":"1\u20133","key":"89_CR27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.drugalcdep.2008.07.013","volume":"99","author":"ES Jones","year":"2009","unstructured":"Jones, E. S., Moore, B. A., Sindelar, J. L., O'Connor, P. G., Schottenfeld, R. S., & Fiellin, D. A. (2009). Cost analysis of clinical and office-based treatment of opioid dependence: Results with methadone and buprenorphine in clinically stable patients. Drug and Alcohol Dependence, 99(1\u20133), 132\u2013140.","journal-title":"Drug and Alcohol Dependence"},{"key":"89_CR28","volume-title":"Student achievement through staff development","author":"B Joyce","year":"2002","unstructured":"Joyce, B., & Showers, B. (2002). Student achievement through staff development (3rd ed.). Alexandria: Association for Supervision and Curriculum Development.","edition":"3"},{"key":"89_CR29","first-page":"2016","volume-title":"Probation and parole in the United States","author":"D Kaeble","year":"2018","unstructured":"Kaeble, D. (2018). Probation and parole in the United States (p. 2016). Washington, DC: U.S. Department of Justice, Office of Justice Programs, Bureau of Justice Statistics."},{"key":"89_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4137\/SART.S5452","volume":"5","author":"KL Kjome","year":"2011","unstructured":"Kjome, K. L., & Moeller, G. F. (2011). Long-acting injectable naltrexone for the management of patients with opioid dependence. Substance Abuse, 5, 1\u20139. https:\/\/doi.org\/10.4137\/SART.S5452 .","journal-title":"Substance Abuse"},{"issue":"4","key":"89_CR31","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.evalprogplan.2011.02.004","volume":"34","author":"HK Knudsen","year":"2011","unstructured":"Knudsen, H. K., Abraham, A. J., & Oser, C. B. (2011). Barriers to the implementation of medication-assisted treatment for substance use disorders: The importance of funding policies and medical infrastructure. Evaluation Program Planning, 34(4), 375\u2013381.","journal-title":"Evaluation Program Planning"},{"issue":"12","key":"89_CR32","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1377\/hlthaff.2017.0890","volume":"36","author":"N Krawczyk","year":"2017","unstructured":"Krawczyk, N., Picher, C. E., Feder, K. A., & Saloner, B. (2017). Only one in twenty justice-referred adults in specialty treatment for opioid use receive methadone or buprenorphine. Health Affairs, 36(12), 2046\u20132053.","journal-title":"Health Affairs"},{"key":"89_CR33","doi-asserted-by":"crossref","DOI":"10.4324\/9781315721224","volume-title":"What works (and doesn\u2019t) in reducing recidivism","author":"EJ Latessa","year":"2014","unstructured":"Latessa, E. J., Listwan, S. J., & Koetzle, D. (2014). What works (and doesn\u2019t) in reducing recidivism. Waltham: Elsevier, Inc."},{"issue":"13","key":"89_CR34","first-page":"110","volume":"374","author":"JD Lee","year":"2015","unstructured":"Lee, J. D., Friedmann, P. D., Kinlock, T. W., Nunes, E. V., Boney, T. Y., Hoskinson, R. A., et al. (2015). Extended-release naltrexone to prevent opioid relapse in criminal justice offenders. New England Journal of Medicine, 374(13), 110\u2013117.","journal-title":"New England Journal of Medicine"},{"key":"89_CR35","volume-title":"Legality of denying access to medication assisted treatment in the criminal justice system","author":"Legal Action Center","year":"2011","unstructured":"Legal Action Center. (2011). Legality of denying access to medication assisted treatment in the criminal justice system. New York: Author."},{"key":"89_CR36","first-page":"611","volume":"6","author":"MW Lipsey","year":"1999","unstructured":"Lipsey, M. W. (1999). Can rehabilitative programs reduce the recidivism of juvenile offenders? An inquiry into the effectiveness of practical programs. Virginia Journal of Social Policy & Law, 6, 611\u2013641.","journal-title":"Virginia Journal of Social Policy & Law"},{"issue":"1","key":"89_CR37","first-page":"13","volume":"82","author":"BK Lovins","year":"2018","unstructured":"Lovins, B. K., Cullen, F. T., Latessa, E. J., & Lero Jonson, C. (2018). Probation officer as a coach: Building a new professional identity. Federal Probation, 82(1), 13\u201319.","journal-title":"Federal Probation"},{"key":"89_CR38","volume-title":"Painting the current picture: A national report on drug courts and other problem-solving courts in the United States","author":"DB Marlow","year":"2016","unstructured":"Marlow, D. B., Hardin, C. D., & Fox, C. L. (2016). Painting the current picture: A national report on drug courts and other problem-solving courts in the United States. Alexandria: National Drug Court Institute, National Association of drug court professionals."},{"issue":"3","key":"89_CR39","first-page":"CD002209","volume":"8","author":"RP Mattick","year":"2009","unstructured":"Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews, 8(3), CD002209.","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"89_CR40","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jsat.2012.10.004","volume":"44","author":"H Matusow","year":"2013","unstructured":"Matusow, H., Dickman, S. L., Rich, J. D., Fong, C., Dumont, D. M., Harin, C., et al. (2013). Medication assisted treatment in US drug courts: Results from a nationwide survey of availability, barriers and attitudes. Journal of Substance Abuse Treatment, 44(5), 473\u2013480.","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"89_CR41","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0740-5472(03)00247-2","volume":"26","author":"D McCarty","year":"2004","unstructured":"McCarty, D., Rieckmann, T., Green, C., Gallon, S., & Knudsen, J. (2004). Training rural practitioners to use buprenorphine; using the change book to facilitate technology transfer. Journal of Substance Abuse Treatment, 26(3), 203\u2013208. https:\/\/doi.org\/10.1016\/S0740-5472(03)00247-2 .","journal-title":"Journal of Substance Abuse Treatment"},{"key":"89_CR42","doi-asserted-by":"crossref","unstructured":"Meltzer, E. C., Rybin, D, Saitz, R., Samet, J. H., Schwartz, S. L., & Butler, S.F., Liebschutz, J. M. (2011). Identifying prescription opioid use disorder in primary care: Diagnostic characteristics of the Current Opioid Misuse Measure (COMM) Pain, 152, 397\u2013402.","DOI":"10.1016\/j.pain.2010.11.006"},{"issue":"1","key":"89_CR43","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/08897077.2015.1129389","volume":"37","author":"SG Mitchell","year":"2016","unstructured":"Mitchell, S. G., Willet, J., Monico, L. B., James, A., Rudes, D. S., Viglioni, J., Schwartz, R. P., et al. (2016). Community correctional agent\u2019s views of medication-assisted treatment: Examining their influence on treatment referrals and community supervision practices. Substance Abuse, 37(1), 127\u2013133.","journal-title":"Substance Abuse"},{"key":"89_CR44","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jsat.2017.07.001","volume":"85","author":"Jake R. Morgan","year":"2018","unstructured":"Morgan, J. R., Schackman, B. R., Leff, J. A., Linas, B. P., & Walley, A. Y. (2018). Injectable naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population.Journal of Substance Abuse Treatment, 85, 90\u201396. https:\/\/doi.org\/10.1016\/j.jsat.2017.07.001 .","journal-title":"Journal of Substance Abuse Treatment"},{"key":"89_CR45","volume-title":"Resolution of the board of directors on the availability of medically assisted treatment (M.A.T.) for addiction in drug courts","author":"National Association of Drug Court Professionals","year":"2011","unstructured":"National Association of Drug Court Professionals. (2011). Resolution of the board of directors on the availability of medically assisted treatment (M.A.T.) for addiction in drug courts. Alexandria: Author."},{"key":"89_CR46","volume-title":"Telehealth in state Substance use disorder (SUD) services","author":"National Association of State Alcohol and Drug Abuse Directors, Inc.","year":"2009","unstructured":"National Association of State Alcohol and Drug Abuse Directors, Inc. (2009). Telehealth in state Substance use disorder (SUD) services. Washington, DC: Author."},{"key":"89_CR47","volume-title":"Principles of drug addiction treatment: A research-based guide","author":"National Institute on Drug Abuse","year":"2018","unstructured":"National Institute on Drug Abuse. (2018). Principles of drug addiction treatment: A research-based guide (3rd ed.). Rockville: Substance Abuse and Mental Health Services Administration.","edition":"3"},{"issue":"2","key":"89_CR48","first-page":"1","volume":"11","author":"BR Nordstrom","year":"2016","unstructured":"Nordstrom, B. R., & Marlowe, D. B. (2016). Medication-assisted treatment for opioid use disorders in drug courts. National Drug Court Institute, Drug Court Practitioner Fact Sheet, 11(2), 1\u201316.","journal-title":"National Drug Court Institute, Drug Court Practitioner Fact Sheet"},{"key":"89_CR49","first-page":"CD010862","volume":"12","author":"AE Perry","year":"2013","unstructured":"Perry, A. E., Neilson, M., Martyn-St. James, M., Glanville, J. M., McCool, R., Duffy, S., & Hewitt, C. (2013). Pharmacological interventions for drug-using offenders. Cochrane Database of Systematic Reviews, 12, CD010862.","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"89_CR50","volume-title":"An overview of medication-assisted treatment for opioid use disorders for criminal justice-involved individuals","author":"J Reichert","year":"2017","unstructured":"Reichert, J., Gleicher, L., & Salisbury-Afshar, E. (2017). An overview of medication-assisted treatment for opioid use disorders for criminal justice-involved individuals. Chicago: Illinois Criminal Justice Information Authority."},{"issue":"9991","key":"89_CR51","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S0140-6736(14)62338-2","volume":"386","author":"J Rich","year":"2015","unstructured":"Rich, J., McKenzie, M., Larney, S., Wong, J., Tran, L., Clarke, J., et al. (2015). Methadone continuation versus forced withdrawal on incarceration in a combined U.S. prison and jail: A randomized, open-label trial. Lancet, 386(9991), 350\u2013359.","journal-title":"Lancet"},{"key":"89_CR52","doi-asserted-by":"publisher","unstructured":"Richmond, L. M. (2018). Court finds substance users can be jailed for relapsing while on probation. Psychiatric News. https:\/\/doi.org\/10.1176\/appi.pn.2018.8b16 .","DOI":"10.1176\/appi.pn.2018.8b16"},{"key":"89_CR53","unstructured":"Ross Johnson, S. (2018). Gaps in providers\u2019 abilty to prescribe buprenorphine hinder opioid treatment efforts. Modern Healthcare. Retrieved from https:\/\/www.modernhealthcare.com\/article\/20180223\/NEWS\/180229950 ."},{"issue":"5","key":"89_CR54","doi-asserted-by":"publisher","first-page":"917","DOI":"10.2105\/AJPH.2012.301049","volume":"103","author":"RP Schwartz","year":"2013","unstructured":"Schwartz, R. P., Gryczynski, J., O\u2019Grady, K. E., Sharfstein, J. M., Warren, G., Olsen, Y., et al. (2013). Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009. American Journal of Public Health, 103(5), 917\u2013922.","journal-title":"American Journal of Public Health"},{"key":"89_CR55","volume-title":"JAMA Forum","author":"JM Sharfstein","year":"2018","unstructured":"Sharfstein, J. M. (2018). A new Year\u2019s wish on opioids. In JAMA Forum Retrieved from https:\/\/newsatjama.jama.com\/2018\/01\/03\/jama-forum-a-new-years-wish-on-opioids\/ ."},{"issue":"2","key":"89_CR56","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jsat.2004.06.001","volume":"27","author":"DD Simpson","year":"2004","unstructured":"Simpson, D. D. (2004). A conceptual framework for drug treatment process and outcomes. Journal of Substance Abuse Treatment, 27(2), 99\u2013121.","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"89_CR57","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1136\/qshc.8.2.92","volume":"8","author":"IJ Smeele","year":"1999","unstructured":"Smeele, I. J., Grol, M., Van Schayck, R. P. T., Van den Bosch, W. J. H., & Muris, J. W. M. (1999). Can small group education and peer review improve care for patients with asthma\/chronic obstructive pulmonary disease? Quality in Health Care, 8(2), 92\u201398.","journal-title":"Quality in Health Care"},{"issue":"5","key":"89_CR58","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1017\/S146114570700836X","volume":"11","author":"M Soyka","year":"2008","unstructured":"Soyka, M., Singg, C., Koller, G., & Kuefner, H. (2008). Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: Results form a randomized study. International Journal of Neuropsychopharmacology, 11(5), 641\u2013653. https:\/\/doi.org\/10.1017\/S146114570700836X .","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"89_CR59","volume-title":"The TEDS report","author":"Substance Abuse and Mental Health Services Administration","year":"2014","unstructured":"Substance Abuse and Mental Health Services Administration. (2014). Few substance abuse treatment admissions are referred by employers. In The TEDS report. Rockville: Author."},{"key":"89_CR60","volume-title":"Medications for opioid use disorder: For healthcare and addiction professionals, policymakers, patients, and families. TIP 63","author":"Substance Abuse and Mental Health Services Administration","year":"2018","unstructured":"Substance Abuse and Mental Health Services Administration. (2018). Medications for opioid use disorder: For healthcare and addiction professionals, policymakers, patients, and families. TIP 63. Rockville: Author Retrieved from https:\/\/store.samhsa.gov\/system\/files\/sma18-5063fulldoc.pdf ."},{"issue":"3","key":"89_CR61","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jsat.2006.12.019","volume":"32","author":"FS Taxman","year":"2007","unstructured":"Taxman, F. S., Perdoni, M. L., & Harrison, L. D. (2007). Drug treatment services for adult offenders: The state of the state. Journal of Substance Abuse Treatment, 32(3), 239\u2013254.","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"89_CR62","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jsat.2007.01.002","volume":"32","author":"FS Taxman","year":"2007","unstructured":"Taxman, F. S., Young, D. W., Wiersema, B., Rhodes, A., & Mitchell, S. (2007). National Criminal Justice Treatment Practices survey: Multilevel survey methods and procedures. Journal of Substance Abuse Treatment, 32(3), 225\u2013238.","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"89_CR63","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1176\/appi.ps.201300256","volume":"65","author":"CP Thomas","year":"2014","unstructured":"Thomas, C. P., Fullerton, C. A., Montejano, K. M., Lyman, D. R., Doughety, R. H., et al. (2014). Medication-assisted treatment with buprenorphine: Assessing the evidence. Psychiatric Services, 65(2), 158\u2013170.","journal-title":"Psychiatric Services"},{"key":"89_CR64","volume-title":"Statement from FDA commissioner Scott Gottlieb, M.D., on the agency\u2019s continued efforts to promote the safe adoption of medication-assisted treatment for opioid addiction","author":"U.S. Food & Drug Administration","year":"2017","unstructured":"U.S. Food & Drug Administration. (2017). Statement from FDA commissioner Scott Gottlieb, M.D., on the agency\u2019s continued efforts to promote the safe adoption of medication-assisted treatment for opioid addiction [press release]. Retrieved from https:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm576752.htm ."},{"key":"89_CR65","volume-title":"Correctional counseling and rehabilitation","author":"P Van Voorhis","year":"2014","unstructured":"Van Voorhis, P., & Salisbury, E. J. (2014). Correctional counseling and rehabilitation. Waltham: Elsevier, Inc."},{"key":"89_CR66","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1056\/NEJMp1402780","volume":"370","author":"ND Volkow","year":"2014","unstructured":"Volkow, N. D., Frieden, T. R., Hyde, P. S., & Cha, S. S. (2014). Medication-assisted therapies\u2014Tackling the opioid overdose epidemic. The New England Journal of Medicine, 370, 2063\u20132066. https:\/\/doi.org\/10.1056\/NEJMp1402780 .","journal-title":"The New England Journal of Medicine"},{"issue":"9","key":"89_CR67","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s11606-008-0686-x","volume":"23","author":"AY Walley","year":"2008","unstructured":"Walley, A. Y., Alperen, J. K., Cheng, D. M., Botticelli, M., Castro-Donlan, C., Samet, J. H., & Alford, D. P. (2008). Office-based management of opioid dependence with buprenorphine: Clinical practices and barriers. Journal of General Internal Medicine, 23(9), 1393\u20131398. https:\/\/doi.org\/10.1007\/s11606-008-0686-x .","journal-title":"Journal of General Internal Medicine"},{"key":"89_CR68","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1001\/archgenpsychiatry.2011.121","volume":"68","author":"RD Weiss","year":"2011","unstructured":"Weiss, R. D., Potter, J. S., Fiellin, D. A., Byrne, M., Connery, H. S., Dickinson, W., et al. (2011). Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial. Archives of General Psychiatry, 68, 1238\u20131246.","journal-title":"Archives of General Psychiatry"},{"issue":"16","key":"89_CR69","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1001\/jama.2013.280377","volume":"310","author":"E Wood","year":"2013","unstructured":"Wood, E., Samet, J. H., & Volkow, N. D. (2013). Physician education in addiction medicine. JAMA, 310(16), 1673\u20131674. https:\/\/doi.org\/10.1001\/jama.2013.280377 .","journal-title":"JAMA"}],"container-title":["Health & Justice"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40352-019-0089-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40352-019-0089-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40352-019-0089-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T22:51:35Z","timestamp":1608072695000},"score":1,"resource":{"primary":{"URL":"https:\/\/healthandjusticejournal.biomedcentral.com\/articles\/10.1186\/s40352-019-0089-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,28]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["89"],"URL":"https:\/\/doi.org\/10.1186\/s40352-019-0089-6","relation":{},"ISSN":["2194-7899"],"issn-type":[{"value":"2194-7899","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,28]]},"assertion":[{"value":"16 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approved by agency\u2019s Institutional Review Board.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"NA (Article reports no individual participant data).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"10"}}